Preventing preterm birth: New approaches to labour therapeutics using Nanoparticles

Goldenberg, 2008, Epidemiology and causes of preterm birth, Lancet, 371, 75, 10.1016/S0140-6736(08)60074-4 Haas, 2012, Tocolytic therapy for preterm delivery: systematic review and network meta-analysis, BMJ, 345, e6226, 10.1136/bmj.e6226 De Jong, 2008, Drug delivery and nanoparticles:applications and hazards, Int J Nanomed, 3, 133, 10.2147/IJN.S596 Saigal, 2008, An overview of mortality and sequelae of preterm birth from infancy to adulthood, Lancet, 371, 261, 10.1016/S0140-6736(08)60136-1 Goldenberg, 2002, The management of preterm labor, Obstet Gynecol, 100, 1020 Di Renzo, 2006, Guidelines for the management of spontaneous preterm labor, J Perinat Med, 34, 359, 10.1515/JPM.2006.073 Faye-Petersen, 2008, The placenta in preterm birth, J Clin Pathol, 61, 1261, 10.1136/jcp.2008.055244 Khan, 2015, Economic costs associated with moderate and late preterm birth: a prospective population-based study, BJOG, 122, 1495, 10.1111/1471-0528.13515 Haas, 2014, Short-term tocolytics for preterm delivery - current perspectives, Int J Womens Health, 6, 343, 10.2147/IJWH.S44048 Haram, 2015, Tocolysis for acute preterm labor: does anything work, J Matern Fetal Neonatal Med, 28, 371, 10.3109/14767058.2014.918095 van Vliet, 2014, Preterm labor: current pharmacotherapy options for tocolysis, Expet Opin Pharmacother, 15, 787, 10.1517/14656566.2014.889684 Syme, 2004, Drug transfer and metabolism by the human placenta, Clin Pharmacokinet, 43, 487, 10.2165/00003088-200443080-00001 Cho, 2008, Therapeutic nanoparticles for drug delivery in cancer, Clin Cancer Res., 14, 1310, 10.1158/1078-0432.CCR-07-1441 Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv Drug Deliv Rev, 55, 329, 10.1016/S0169-409X(02)00228-4 Bhatia, 2016 Menezes, 2011, Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure, Curr Pharmaceut Biotechnol, 12, 731, 10.2174/138920111795471010 Hua, 2013, The use of lipid-based nanocarriers for targeted pain therapies, Front Pharmacol, 4, 143, 10.3389/fphar.2013.00143 Alexis, 2008, Factors affecting the clearance and biodistribution of polymeric nanoparticles, Mol Pharm, 5, 505, 10.1021/mp800051m Salata, 2004, Applications of nanoparticles in biology and medicine, J Nanobiotechnol, 2, 3, 10.1186/1477-3155-2-3 Moghimi, 2001, Long-circulating and target-specific nanoparticles: theory to practice, Pharmacol Rev, 53, 283 Hull, 2014, Highlights of recent developments and trends in cancer nanotechnology research–view from NCI alliance for nanotechnology in Cancer, Biotechnol Adv, 32, 666, 10.1016/j.biotechadv.2013.08.003 Morris, 2014, Nanotechnologies in cancer treatment and diagnosis, J Natl Compr Cancer Netw JNCCN, 12, 1727, 10.6004/jnccn.2014.0175 Moise, 1990, Placental transfer of indomethacin in the human pregnancy, Am J Obstet Gynecol, 162, 549, 10.1016/0002-9378(90)90427-9 Major, 1994, Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate, Am J Obstet Gynecol, 170, 102, 10.1016/S0002-9378(94)70392-2 Suarez, 2001, Indomethacin tocolysis and intraventricular hemorrhage, Obstet Gynecol, 97, 921 Moise, 1993, Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use, Am J Obstet Gynecol, 168, 1350, 10.1016/S0002-9378(11)90763-7 Suarez, 2002, The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate, Am J Obstet Gynecol, 187, 886, 10.1067/mob.2002.127464 Vermillion, 1997, The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age, Am J Obstet Gynecol, 177, 256, 10.1016/S0002-9378(97)70184-4 Myllynen, 2008, Kinetics of gold nanoparticles in the human placenta, Reprod Toxicol, 26, 130, 10.1016/j.reprotox.2008.06.008 Wick, 2010, Barrier capacity of human placenta for nanosized materials, Environ Health Perspect, 118, 432, 10.1289/ehp.0901200 Tuzel, 1980, The fate in vivo of liposomally entrapped drugs in pregnant rats, Biochem Soc Trans, 8, 559, 10.1042/bst0080559 Refuerzo, 2011, Size of the nanovectors determines the transplacental passage in pregnancy: study in rats, Am J Obstet Gynecol, 204, e5 Campagnolo, 2013, Biodistribution and toxicity of pegylated single wall carbon nanotubes in pregnant mice, Part Fibre Toxicol, 10, 21, 10.1186/1743-8977-10-21 Kaga, 2012, Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model, Life Sci, 91, 420, 10.1016/j.lfs.2012.08.021 Chu, 2010, Transfer of quantum dots from pregnant mice to pups across the placental barrier, Small, 6, 670, 10.1002/smll.200902049 Semmler-Behnke, 2008, Biodistribution of 1.4- and 18-nm gold particles in rats, Small, 4, 2108, 10.1002/smll.200800922 Lonner, 2015, Potential utility of liposome bupivacaine in orthopedic surgery, Am J Orthop (Belle Mead NJ), 44, 111 Stone, 2016, Liposomal amphotericin B (AmBisome((R))): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions, Drugs, 76, 485, 10.1007/s40265-016-0538-7 Xing, 2015, Efficacy and cardiotoxicity of liposomal doxorubicin-based chemotherapy in advanced breast cancer: a meta-analysis of ten randomized controlled trials, PLoS One, 10, e0133569, 10.1371/journal.pone.0133569 Huszar, 1982, Biochemistry and pharmacology of the myometrium and labor: regulation at the cellular and molecular levels, Am J Obstet Gynecol, 142, 225, 10.1016/S0002-9378(16)32341-9 Paul, 2015, 57A Ding, 2006, Advanced drug delivery systems that target the vascular endothelium, Mol Interv, 6, 98, 10.1124/mi.6.2.7 Hua, 2013, Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies, Front Pharmacol, 4, 127, 10.3389/fphar.2013.00127 Koning, 2003, Targeted drug delivery systems for the intracellular delivery of macromolecular drugs, Drug Discov Today, 8, 482, 10.1016/S1359-6446(03)02699-0 Metselaar, 2005, Liposomes in the treatment of inflammatory disorders, Expet Opin Drug Deliv, 2, 465, 10.1517/17425247.2.3.465 Parkington, 2014, Diminished hERG K+ channel activity facilitates strong human labour contractions but is dysregulated in obese women, Nat Commun, 5, 4108, 10.1038/ncomms5108 Poste, 1976, Lipid vesicles as carriers for introducing biologically active materials into cells, Meth Cell Biol, 14, 33, 10.1016/S0091-679X(08)60468-9 Senior, 1987, Fate and behavior of liposomes in vivo: a review of controlling factors, Crit Rev Ther Drug Carrier Syst, 3, 123 Adan, 1995, Rat oxytocin receptor in brain, pituitary, mammary gland, and uterus: partial sequence and immunocytochemical localization, Endocrinology, 136, 4022, 10.1210/endo.136.9.7649111 Paul, 2017, Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor, Am J Obstet Gynecol, 216, 10.1016/j.ajog.2016.08.027 Vrachnis, 2011, The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents, Int J Endocrinol, 2011, 350546, 10.1155/2011/350546 Flenady, 2014, Oxytocin receptor antagonists for inhibiting preterm labour, Cochrane Database Syst Rev, Cd004452 Thornton, 2015, Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study, Br J Clin Pharmacol, 80, 740, 10.1111/bcp.12646 Refuerzo, 2016, Uterus-targeted liposomes for preterm labor management: studies in pregnant mice, Sci Rep, 6, 34710, 10.1038/srep34710 Refuerzo, 2015, Liposomes: a nanoscale drug carrying system to prevent indomethacin passage to the fetus in a pregnant mouse model, Am J Obstet Gynecol, 212 Poste, 1976, Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells, Proc Natl Acad Sci U S A, 73, 1603, 10.1073/pnas.73.5.1603 Mehedintu, 2014, Endometriosis still a challenge, J Med life, 7, 349 Polat, 2015, In vitro fertilization for endometriosis-associated infertility, Women's health (London, England), 11, 633, 10.2217/whe.15.50 Schwager, 2011, The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model, Hum Reprod, 26, 2344, 10.1093/humrep/der195 Quattrone, 2015, The targeted delivery of interleukin 4 inhibits development of endometriotic lesions in a mouse model, Reprod Sci, 22, 1143, 10.1177/1933719115578930 Schwager, 2009 King, 2016, Tumor-homing peptides as tools for targeted delivery of payloads to the placenta, Sci adv, 2, e1600349, 10.1126/sciadv.1600349 Blencowe, 2013, Born too soon: the global epidemiology of 15 million preterm births, Reprod Health, 10, S2, 10.1186/1742-4755-10-S1-S2 Ilicic, 2017, The expression of genes involved in myometrial contractility changes during ex situ culture of pregnant human uterine smooth muscle tissue, J Smooth Muscle Res, 53, 73, 10.1540/jsmr.53.73 Ilicic, 2017, Modulation of progesterone receptor isoform expression in pregnant human myometrium, BioMed Res Int, 2017, 4589214, 10.1155/2017/4589214 Keelan, 2015, Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy, Nanomedicine (Lond), 10, 2229, 10.2217/nnm.15.48